FDA Approves New Drug to Treat Bladder Cancer
Tecentriq boosted survival in small trialContinue Reading
Tecentriq boosted survival in small trialContinue Reading
Exercise also touted as an answer to ‘nocturia’Continue Reading
Procedure partially blocks blood flow to the gland and appears to ease the night need, but skeptics existContinue Reading
But odds are small, and experts want it to remain on market, although newer drugs are availableContinue Reading
Researchers say threat is worrisome because children are at high risk of kidney complicationsContinue Reading
Chances of secondary cancers increased, but study authors stressed the overall risk was lowContinue Reading
Specialist says grocery-store varieties aren’t strong enough for the jobContinue Reading
Specialist says grocery-store varieties aren’t strong enough for the jobContinue Reading
Inability to control bowels often stems from muscle damageContinue Reading
Odds for the disease are also climbing faster among women than men, research showsContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.